Syphilis appeared in Italy in 1498 just after Columbus had returned from the New World. This later led to suggestions that it had been brought back from the New World, in exchange for the many European illnesses that decimated the populations of North American Indians. Exposed to a virgin population new infections can be particularly virulent and during the subsequent … [Read more...] about Pharmacosis: The day the music died
Pharmacosis: Terminator Algorithm
The single commonest question to RxISK.org has been about dependence on and withdrawal from treatments, such as anticonvulsants, statins, diuretics and others. We often think that it is only drugs of abuse that can cause dependence and withdrawal but in fact an astonishing number, perhaps most medicines, can cause problems (see Medicine Induced Stress Syndromes, Dependence and … [Read more...] about Pharmacosis: Terminator Algorithm
Pharmacosis: Trigger Algorithm
The first descriptions of a drug causing suicide came in 1955. A few years later in 1958 and again in 1959 the problem was described with imipramine. Treatment induced suicide became a prominent media issue in 1990 with a paper by Teicher and Cole. But it was not until 2004 that regulators and companies conceded that these drugs can cause a problem. There are now 38 drugs … [Read more...] about Pharmacosis: Trigger Algorithm
Pharmacosis
There is a new Contagion out there. Kate Winslet beware. Disease with no name This new epidemic has rapidly become at least the fourth leading cause of death and disability - it may even be the greatest cause of death because all we have counted so far are deaths in hospital where such deaths can be spotted. Where every other disease comes with a guideline for its management, … [Read more...] about Pharmacosis
The Unbearable Lightness of Being
This is the last of 3 posts laying out the philosophical basis for RxISK.org which will be live in the next few weeks. The others are Cri de Coeur & Once is Never. In his masterpiece on love and life The Unbearable Lightness of Being, Milan Kundera faces us with a dilemma about the important things in life “einmal ist keinmal” – “once is never”. Academics need lovers But … [Read more...] about The Unbearable Lightness of Being
Once is Never
This is the second of 3 posts laying out the philosophical basis for RxISK.org which will be live in the next few weeks. The others are Cri de Coeur & the Unbearable lightness of being. In Cri de Coeur, I outlined a scenario in which a treatment that causes suicide when put into good trials without any manipulation of the data, any statistical artifice, or any ghostwriting … [Read more...] about Once is Never
Cri de Coeur
This is the first of 3 posts laying out the philosophical basis for RxISK.org which will be live in the next few weeks. The others are Once is Never & the Unbearable lightness of being. “[I suggest] a meeting with yourself and your reviewers. I have spoken in public on these issues and offered to speak on any platform. I’ve visited the MHRA [British equivalent of FDA]. … [Read more...] about Cri de Coeur
The Day the Lyrics Lied
This post was written by Dr Irene Campbell-Taylor, a former Clinical Neuroscientist and Assistant Professor of Medicine at the University of Toronto. It is essential to read the marketing copy of pharmaceutical companies with care and attention for critical hidden details. It is rare to find an announcement with such obvious errors and dangerous suggestions up front as those … [Read more...] about The Day the Lyrics Lied
Every Drink Spiked
This post is written anonymously. I outlined how my daughter Petra came to take Cymbalta on this blog a few months ago (see Petra’s story; also see Symbolta of Sorts). This post tells of events that led to her coming off. Petra is an enthusiast for motor sport events. She has been on track days, hill climbs and driver training events. She is a member of an Italian car club. … [Read more...] about Every Drink Spiked
A Symbolta of Sorts
In the early 1990s, Prozac was riding high but Lilly were planning its successor. The leading candidate was duloxetine – a dual inhibitor of both serotonin and norepinephrine reuptake as the older tricylic antidepressants (TCAs) had been. The company approached me in 1992 to recruit patients to a clinical trial of the new drug but before the trial could start duloxetine was … [Read more...] about A Symbolta of Sorts